Putting the brake on accelerated lung function decline in asthma
- PMID: 29444922
- DOI: 10.1183/13993003.02630-2017
Putting the brake on accelerated lung function decline in asthma
Conflict of interest statement
Conflict of interest: D. Shaw reports receiving advisory board fees from GlaxoSmithKline, Novartis and AstraZeneca, and travel fees from TEVA and AstraZeneca.
Comment on
-
Predictors of accelerated decline in lung function in adult-onset asthma.Eur Respir J. 2018 Feb 14;51(2):1701785. doi: 10.1183/13993003.01785-2017. Print 2018 Feb. Eur Respir J. 2018. PMID: 29444915
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical